News and Event Archive

Exco InTouch Complimentary Webinar: Take Control of Your Trials

Posted by cwatson

On November 10, 2011 Exco InTouch sponsored a Complimentary Web Seminar entitled:

Take Control of Patient Communication, Reduce Missing Data, and Maximize Compliance and Retention

The Challenge - Both FDA and the EMEA have put greater emphasis on the collection of full data sets for trial participants, with a particular focus being on the collection of data for critical endpoints at specified time points, as well as reason for withdrawal from study medication data. Statistically, over 85% of clinical trials in the US fail to recruit or retain enough patients, with the average patient drop-out rate across all clinical trials surveyed at 30%. High non-completion rates such as these can result in decreased quality of data, ineffective use of time and reduced statistical power in a study.

read full post

News Archive

Exco InTouch Success Stories - Testimonial

Follow us

InTouch Clinical - Secure and regulatory compliant mobile solutions automatically schedule and deliver text messages directly to patients and caregivers.

Secure & regulatory compliant mobile solutions which automatically schedule & deliver text messages to patient & caregiver cell phones

ePRO Cell - The world’s first validated eDiary solution on a mobile phone. Secure, smarter and easier to gather crucial PRO data.

The world’s first validated ePRO solution on a cell phone. A secure, smarter & easier method of collecting crucial PRO data

ePRO APP - A simpler, more efficient way to gather data from subjects, care givers and sites that is fast to set up and easy to use.

A simpler, more efficient way to gather PRO data from subjects, caregivers & sites, that is quick to set up & easy to use by all participants

InTouch Recruit - Enhancing recruitment into clinical trials allows sponsor companies to reduce time and ultimately to bring new drugs to market faster.

Enhancing clinical trials recruitment, allowing sponsor companies to reduce timelines & ultimately bring new drugs to market faster